Lee A Albacker

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 26

Top Venues

JCO precision oncology

PloS one

NPJ precision oncology

Neuro-oncology advances

Foundation Medicine Inc

Harvard University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Foundation Medicine Inc

United States

Senior Scientist :: Genome Science and Research

Harvard University Sep 01 2011 - Jun 30 2015

United States

Post-doc :: Department of Systems Biology

Education History

Harvard University

United States

PHD :: Program on Immunology

Publications

Douglas I Lin, Julia C F Quintanilha, Natalie Danziger, Lixin Lang, Diane Levitan, Cynthia Hayne, Matthew C Hiemenz, David L Smith, Lee A Albacker, Jeffrey Leibowitz, Douglas A Mata, Brennan Decker, Sotirios Lakis, Nimesh R Patel, Ryon P Graf, Julia A Elvin, Jeffrey S Ross, Varun Pattani, Richard S P Huang, Amy K Wehn
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab. NPJ precision oncology 8 (1) (2024)
Niamh Coleman, Kathrina L Marcelo, Julia F Hopkins, Nusrat Israr Khan, Robyn R Du, Lingzhi Hong, Edward Park, Binaifer Balsara, Mollie Leoni, Curtis R Pickering, Jeffrey N Myers, John Victor Heymach, Lee A Albacker, David S Hong, Maura Gillison, Xiuning Li
HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma. JCO precision oncology 7 (2023)
Emily L Hoskins, Eric Samorodnitsky, Michele R Wing, Julie A Wallace Reeser, Julia F Hopkins, Karthikeyan Murugesan, Zheng Kuang, Raven Vella, Leah Stein, Zachary Risch, Lianbo Yu, Serifat O Adebola, Anoosha Paruchuri, John Carpten, Jad Chahoud, Stephen B Edge, Jill M Kolesar, Martin McCarter, Kenneth G Nepple, Matthew J Reilley, Courtney Scaife, Abhishek Tripathi, Nancy Single, Richard S P Huang, Lee A Albacker, Sameek Roychowdhury
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. JCO precision oncology 7 (2023)
Nicholas C Turner, A Douglas Laird, Melinda L Telli, Hope S Rugo, Audrey Mailliez, Johannes Ettl, Eva-Maria Grischke, Lida A Mina, Judith Balmaña, Peter Andreas Fasching, Sara Alsterlind Hurvitz, Julia F Hopkins, Lee A Albacker, Jijumon Chelliserry, Ying Chen, Umberto Conte, Andrew M Wardley, Mark E Robson
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study. NPJ breast cancer 9 (1) (2023)
Emily L Hoskins, Eric Samorodnitsky, Michele R Wing, Julie A Wallace Reeser, Julia F Hopkins, Karthikeyan Murugesan, Zheng Kuang, Raven Vella, Leah Stein, Zachary Risch, Lianbo Yu, Serifat O Adebola, Anoosha Paruchuri, John Carpten, Jad Chahoud, Stephen B Edge, Jill M Kolesar, Martin McCarter, Kenneth G Nepple, Matthew J Reilley, Courtney Scaife, Abhishek Tripathi, Nancy Single, Richard S P Huang, Lee A Albacker, Sameek Roychowdhury
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. JCO precision oncology 7 (2023)
Emily L Hoskins, Eric Samorodnitsky, Michele R Wing, Julie A Wallace Reeser, Julia F Hopkins, Karthikeyan Murugesan, Zheng Kuang, Raven Vella, Leah Stein, Zachary Risch, Lianbo Yu, Serifat O Adebola, Anoosha Paruchuri, John Carpten, Jad Chahoud, Stephen B Edge, Jill M Kolesar, Martin McCarter, Kenneth G Nepple, Matthew J Reilley, Courtney Scaife, Abhishek Tripathi, Nancy Single, Richard S P Huang, Lee A Albacker, Sameek Roychowdhury
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. JCO precision oncology 7 (2023)
Niamh Coleman, Kathrina L Marcelo, Julia F Hopkins, Nusrat Israr Khan, Robyn R Du, Lingzhi Hong, Edward Park, Binaifer Balsara, Mollie Leoni, Curtis R Pickering, Jeffrey N Myers, John Victor Heymach, Lee A Albacker, David S Hong, Maura Gillison, Xiuning Li
HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma. JCO precision oncology 7 (2023)
Niamh Coleman, Kathrina L Marcelo, Julia F Hopkins, Nusrat Israr Khan, Robyn R Du, Lingzhi Hong, Edward Park, Binaifer Balsara, Mollie Leoni, Curtis R Pickering, Jeffrey N Myers, John Victor Heymach, Lee A Albacker, David S Hong, Maura Gillison, Xiuning Li
HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma. JCO precision oncology 7 (2023)
Niamh Coleman, Kathrina L Marcelo, Julia F Hopkins, Nusrat Israr Khan, Robyn R Du, Lingzhi Hong, Edward Park, Binaifer Balsara, Mollie Leoni, Curtis R Pickering, Jeffrey N Myers, John Victor Heymach, Lee A Albacker, David S Hong, Maura Gillison, Xiuning Li
HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma. JCO precision oncology 7 (2023)
Ericka M Ebot, Daniel L Duncan, Khaled Tolba, David Fabrizio, Garrett M Frampton, Leah A Comment, Lee A Albacker
Deletions on 9p21 are associated with worse outcomes after anti-PD-1/PD-L1 monotherapy but not chemoimmunotherapy. NPJ precision oncology 6 (1) (2022)
Karthikeyan Murugesan, Dexter X Jin, Leah A Comment, David Fabrizio, Priti S Hegde, Julia A Elvin, Brian Alexander, Mia A Levy, Garrett M Frampton, Meagan Montesion, Sameek Roychowdhury, Razelle Kurzrock, Jeffrey S Ross, Lee A Albacker, Richard S P Huang
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer. The oncologist 27 (9) (2022)
Noboru Ishiyama, Matthew O'Connor, Andrei Salomatov, Darlene Romashko, Shalabh Thakur, Ahmet Mentes, Julia F Hopkins, Garrett M Frampton, Lee A Albacker, Anna Kohlmann, Christopher Roberts, Elizabeth Buck
Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects. Cancer research (2022)
Joanne L Blum, A Douglas Laird, Jennifer K Litton, Hope S Rugo, Johannes Ettl, Sara A Hurvitz, Miguel Martin, Henri H Roché, Kyung-Hun Lee, Annabel Goodwin, Ying Chen, Silvana Lanzalone, Jijumon Chelliserry, Akos Czibere, Julia F Hopkins, Lee A Albacker, Lida A Mina
Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Craig Furman, Xiaoling Puyang, Zhaojie Zhang, Zhenhua J Wu, Deepti Banka, Kiran B Aithal, Lee A Albacker, Ming-Hong Hao, Sean Irwin, Amy Kim, Meagan Montesion, Alyssa D Moriarty, Karthikeyan Murugesan, Tuong-Vi Nguyen, Victoria Rimkunas, Tarek Sahmoud, Michael J Wick, Shihua Yao, Xun Zhang, Hao Zeng, Frédéric H Vaillancourt, David M Bolduc, Nicholas Larsen, Guo Zhu Zheng, Sudeep Prajapati, Ping Zhu, Manav Korpal
Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer. Molecular cancer therapeutics 21 (6) (2022)
Radwa Sharaf, Garrett M Frampton, Lee A Albacker
Mutations in the TERC template sequence can be incorporated into the telomeres of human tumors. PloS one 17 (8) (2022)
Radwa Sharaf, Meagan Montesion, Julia F Hopkins, Jiarong Song, Garrett M Frampton, Lee A Albacker
A pan-cancer landscape of telomeric content shows that RAD21 and HGF alterations are associated with longer telomeres. Genome medicine 14 (1) (2022)
Radwa Sharaf, Dean C Pavlick, Garrett M Frampton, Maureen Cooper, Jacqueline Jenkins, Natalie Danziger, James Haberberger, Brian M Alexander, Timothy Cloughesy, William H Yong, Linda M Liau, Phioanh L Nghiemphu, Matthew Ji, Albert Lai, Shakti H Ramkissoon, Lee A Albacker
Erratum to: FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas. Neuro-oncology advances 3 (1) (2021)
Bryan Paul Schneider, Guanglong Jiang, Tarah Jean Ballinger, Fei Shen, Christopher Chitambar, Rita Nanda, Carla Falkson, Filipa C Lynce, Christopher M Gallagher, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Karen Daily, Reshma L Mahtani, Michael A Thompson, Robert Graham, Maureen E Cooper, Dean C Pavlick, Lee A Albacker, Jeffrey Gregg, Jeffrey P Solzak, Yu-Hsiang Chen, Casey L Bales, Erica L Cantor, Bradley A Hancock, Nawal Kassem, Paul Helft, Bert O'Neil, Anna Maria V Storniolo, Sunil S Badve, Kathy D Miller, Milan Radovich
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (4) (2021)
Simon Papillon-Cavanagh, Julia F Hopkins, Shakti H Ramkissoon, Lee A Albacker, Alice M Walsh
Pan-cancer analysis of the effect of biopsy site on tumor mutational burden observations. Communications medicine 1 (2021)
Radwa Sharaf, Dean C Pavlick, Garrett M Frampton, Maureen Cooper, Jacqueline Jenkins, Natalie Danziger, James Haberberger, Brian M Alexander, Timothy Cloughesy, William H Yong, Linda M Liau, Phioanh L Nghiemphu, Matthew Ji, Albert Lai, Shakti H Ramkissoon, Lee A Albacker
FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas. Neuro-oncology advances 3 (1) (2021)
Jacob Rinaldi, Ethan S Sokol, Ryan J Hartmaier, Sally E Trabucco, Garrett M Frampton, Michael E Goldberg, Lee A Albacker, Anneleen Daemen, Gerard Manning
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors. PloS one 15 (5) (2020)
Meagan Montesion, Karthikeyan Murugesan, Dexter X Jin, Radwa Sharaf, Nora Sanchez, Ameet Guria, Max Minker, Gerald Li, Virginia Fisher, Ethan S Sokol, Dean C Pavlick, Jay A Moore, Alan Braly, Gaurav Singal, David Fabrizio, Leah A Comment, Naiyer A Rizvi, Brian M Alexander, Garrett M Frampton, Priti S Hegde, Lee A Albacker
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response. Cancer discovery 11 (2) (2020)
Todd C Knepper, Meagan Montesion, Jeffery S Russell, Ethan S Sokol, Garrett M Frampton, Vincent A Miller, Lee A Albacker, Howard L McLeod, Zeynep Eroglu, Nikhil I Khushalani, Vernon K Sondak, Jane L Messina, Michael J Schell, James A Decaprio, Kenneth Y Tsai, Andrew S Brohl
The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (19) (2019)
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, Matthew D Hellmann, Mark M Awad, Justin F Gainor, Alexa B Schrock, Ryan J Hartmaier, Sally E Trabucco, Laurie Gay, Siraj M Ali, Julia A Elvin, Gaurav Singal, Jeffrey S Ross, David Fabrizio, Peter M Szabo, Han Chang, Ariella Sasson, Sujaya Srinivasan, Stefan Kirov, Joseph Szustakowski, Patrik Vitazka, Robin Edwards, Jose A Bufill, Neelesh Sharma, Sai-Hong I Ou, Nir Peled, David R Spigel, Hira Rizvi, Elizabeth Jimenez Aguilar, Brett W Carter, Jeremy Erasmus, Darragh F Halpenny, Andrew J Plodkowski, Niamh M Long, Mizuki Nishino, Warren L Denning, Ana Galan-Cobo, Haifa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez-Canales, Pamela A Villalobos, Edwin R Parra, Neda Kalhor, Lynette M Sholl, Jennifer L Sauter, Achim A Jungbluth, Mari Mino-Kenudson, Roxana Azimi, Yasir Y Elamin, Jianjun Zhang, Giulia C Leonardi, Fei Jiang, Kwok-Kin Wong, J Jack Lee, Vassiliki A Papadimitrakopoulou, Ignacio I Wistuba, Vincent A Miller, Garrett M Frampton, Jedd D Wolchok, Alice T Shaw, Pasi A Jänne, Philip J Stephens, Charles M Rudin, William J Geese, Lee A Albacker, John Victor Heymach
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma. Cancer discovery 8 (7) (2018)
Michael E Goldberg, Meagan Montesion, Lauren Young, James Suh, Joel Greenbowe, Mark Kennedy, Giuseppe Giaccone, Wallace L Akerley, Afshin Dowlati, Benjamin C Creelan, James K Hicks, Paul J Hesketh, Karen L Kelly, Jonathan W Riess, Vincent A Miller, Philip J Stephens, Garrett M Frampton, Siraj Ali, Jeffrey P Gregg, Lee A Albacker
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC. PloS one 13 (11) (2018)
Lee A Albacker, Jeremy Wu, Peter Smith, Markus Warmuth, Philip J Stephens, Ping Zhu, Lihua Yu, Juliann Chmielecki
Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion. PloS one 12 (11) (2017)

Lee A Albacker.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lee A Albacker